Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Hao‑Lun Luo"'
Autor:
I-Wen Lee, Hung-Jen Wang, Hui-Ying Liu, Yin-Lun Chang, Yen-Tin Wu, Yen Ta Chen, Yuan Tso Cheng, Chih Hsiung Kang, Yao Chi Chuang, Hao-Lun Luo
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 7, Pp 758-763 (2024)
Objective: This study aimed to assess the impact of preoperative chronic kidney disease (CKD) on the oncological outcomes of patients with upper tract urothelial carcinoma (UTUC) who underwent standard radical nephroureterectomy (RNU). Methods: A tot
Externí odkaz:
https://doaj.org/article/55053e9c6c2f4dc79bf6d88ced178012
Autor:
Shih‑Gang Wang, Hao‑Lun Luo, Hung‑Jen Wang, Wen‑Jeng Wu, Wei‑Ming Li, Po‑Hung Lin, See‑Tong Pang, Shian‑Shiang Wang, Jian‑Ri Li, Han‑Yu Weng, Ta‑Yao Tai, Jen‑Shu Tseng, Wun‑Rong Lin, I‑Hsuan Alan Chen, Jen‑Tai Lin, Yuan‑Hong Jiang, Yu‑Khun Lee, Jen Kai Fang, Chao‑Yuan Huang, Wen‑Hsin Tseng, Wei Yu Lin, Chia‑Chang Wu, Shu‑Yu Wu, Pai‑Yu Cheng, Po‑Han Lin, Yung‑Tai Chen, Allen W. Chiu, Bing-Juin Chiang, Chao-Hsiang Chang, Chao-Yuan Huang, Cheng-Huang Shen, Cheng-Kuang Yang, Cheng-Ling Lee, Chen-Hsun Ho, Che-Wei Chang, Chia-Chang Wu, Chieh-Chun Liao, Chien-Hui Ou, Chih-Chen Hsu, Chih-Chin Yu, Chih-Hung Lin, Chih-Ming Lu, Chih-Yin Yeh, Ching-Chia Li, Chi-Ping Huang, Chi-Rei Yang, Chi-Wen Lo, Chuan-Shu Chen, Chung-Hsin Chen, Chung-You Tsai, Chung-Yu Lin, Chun-Hou Liao, Chun-Kai Hsu, Fang-Yu Ku, Hann-Chorng Kuo, Han-Yu Weng, Hao-Han Chang, Hong-Chiang Chang, Hsiao-Jen Chung, Hsin-Chih Yeh, Hsu-Che Huang, Ian-Seng Cheong, I-Hsuan Alan Chen, Jen-Kai Fang, Jen-Shu Tseng, Jen-Tai Lin, Jian-Hua Hong, Jih-Sheng Chen, Jungle Chi-Hsiang Wu, Kai-Jie Yu, Keng-Kok Tan, Kuan-Hsun Huang, Kun-Lin Hsieh, Lian-Ching Yu, Lun-Hsiang Yuan, Hao-Lun Luo, Marcelo Chen, Min-Hsin Yang, Pai-Yu Cheng, Po-Hung Lin, Richard Chen-Yu Wu, See-Tong Pang, Shin-Hong Chen, Shin-Mei Wong, Shiu-Dong Chung, Shi-Wei Huang, Shuo-Meng Wang, Shu-Yu Wu, Steven Kuan-Hua Huang, Ta-Yao Tai, Thomas Y. Hsueh, Ting-En Tai, Victor Chia-Hsiang Lin, Wei-Chieh Chen, Wei-Ming Li, Wei-Yu Lin, Wen-Hsin Tseng, Wen-Jeng Wu, Wun-Rong Lin, Yao-Chou Tsai, Yen-Chuan Ou, Yeong-Chin Jou, Yeong-Shiau Pu, Yi-Chia Lin, Yi-Hsuan Wu, Yi-Huei Chang, Yi-sheng Lin, Yi-Sheng Tai, Yu-Khun Lee, Yuan-Hong Jiang, Yu-Che Hsieh, Yu-Chi Chen, Yu-Ching Wen, Yung-Tai Chen, Zhe-Rui Yang
Publikováno v:
Urological Science, Vol 35, Iss 1, Pp 42-50 (2024)
Purpose:. According to the National Comprehensive Cancer Network guidelines, segmental ureterectomy (SU) of upper tract urothelial carcinoma (UTUC) is a considerable option for selected mid- and distal ureteral urothelial carcinoma (UC). As a UTUC en
Externí odkaz:
https://doaj.org/article/868ccc01ef6d43b89da2a5c22758bb61
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Urothelial carcinoma (UC) is a common cancer characterized by high morbidity and mortality rates. Despite advancements in treatment, challenges such as recurrence and low response rates persist. Antibody-drug conjugates (ADCs) have emerged as a promi
Externí odkaz:
https://doaj.org/article/252b1a6b46b5414f956e2d41ef98ad90
Autor:
Tsung-Han Tsai, Po-Jung Su, Shih-Yu Huang, Ming-Chun Kuo, Chang-Ting Lin, Chia-Che Wu, Hao-Lun Luo, Chien-Hsu Chen, Chih-Chi Chou, Ting-Ting Liu, Chun-Chieh Huang, Kai-Lung Tsai, Yu-Li Su
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background While the treatment guidelines have been established for pure urothelial carcinoma (pUC), patients with variant type urothelial carcinoma (vUC) face limited effective treatment options. The effectiveness of immune checkpoint inhib
Externí odkaz:
https://doaj.org/article/10619625828044718e74366ce2c048cc
Autor:
Ying-Che Huang, Hung-Jen Wang, Min-Tse Sung, Yao-Chi Chuang, Yen-Ta Chen, Yuan-Tso Cheng, Chih-Hsiung Kang, Hui-Ying Liu, Yin-Lun Chang, Po-Hui Chiang, Hao-Lun Luo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo evaluate the prognostic impact of the lowest level of tumor location for upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU).Materials and methodsData were collected from patients with UTUC treated with RNU
Externí odkaz:
https://doaj.org/article/b9fb17d9110b4606b5e6e98cce8bc747
Autor:
Yu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, Chia-Che Wu, Li-Chung Chang, Yi-Hua Chen, Hao-Lun Luo, Chun-Chieh Huang, Ting-Ting Liu, Jei-Ming Peng
Publikováno v:
Cells, Vol 12, Iss 11, p 1471 (2023)
Urothelial carcinoma (UC) is characterized by a high incidence of TP53 mutation, and overcoming resistance to cisplatin-based chemotherapy in UC is a major concern. Wee1 is a G2/M phase regulator that controls the DNA damage response to chemotherapy
Externí odkaz:
https://doaj.org/article/6a121f4ddd694b90a5aae424155b7be5
Autor:
Jei-Ming Peng, Ching-Feng Chiu, Jai-Hong Cheng, Hui-Ying Liu, Yin-Lun Chang, Jia-Wun Luo, Yu-Ting Weng, Hao-Lun Luo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cancer immunotherapy uses the immune system to achieve therapeutic effects; however, its effect is still limited. Therefore, in addition to immune checkpoint-based treatment, the development of other strategies that can inhibit cancer cells from resi
Externí odkaz:
https://doaj.org/article/3ce76e1432b84f32a4780b3eb4f89839
Autor:
Hao-Lun Luo, Yin-Lun Chang, Hui-Ying Liu, Yen-Ting Wu, Ming-Tse Sung, Yu-Li Su, Chun-Chieh Huang, Pei-Chia Wang, Jei-Ming Peng
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7486 (2023)
Versican (VCAN), also known as extracellular matrix proteoglycan 2, has been suggested as a potential biomarker in cancers. Previous research has found that VCAN is highly expressed in bladder cancer. However, its role in predicting outcomes for pati
Externí odkaz:
https://doaj.org/article/8b66ddc74a5c4a20818b9fe8feca1264
Autor:
Yun-Ching Huang, Jui-Ming Liu, Hui-Ying Liu, Yin-Lun Chang, Chih-Shou Chen, Dong-Ru Ho, Chun-Te Wu, Miao-Fen Chen, Hung-Jen Wang, Hao-Lun Luo
Publikováno v:
Cancers, Vol 15, Iss 6, p 1858 (2023)
Background: Oncologic outcomes for pT2N0M0 upper tract urothelial carcinoma (UTUC) after nephroureterectomy are not well defined, with most previous studies focused on a heterogeneous population. Therefore, we aimed to investigate the clinical determ
Externí odkaz:
https://doaj.org/article/096b615b2bc647f0afae124036ffa8d2
Autor:
Chun-Chieh Huang, I-Chieh Chuang, Yu-Li Su, Hao-Lun Luo, Ya-Chun Chang, Jo-Ying Chen, Chang-Chun Hsiao, Eng-Yen Huang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionTo investigate the role of tumor galectin-1 and galectin-3 in patients with lung adenocarcinoma after definitive radiation therapy.MethodsA total of 41 patients with localized lung adenocarcinoma undergoing thoracic radiation therapy with
Externí odkaz:
https://doaj.org/article/76ab405d8f2c4a86ae8192045fe53f15